Ensign Peak Advisors, Inc
Position in DNLI — Denali Therapeutics Inc.
CIK 1454984
SALT LAKE CITY, UT
Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,986,246
+$5,084,403 QoQ
Shares Held
582,669
+13.0% QoQ
Ownership
0.365%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#44
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. DNLI ranks #24 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,986,246 | 582,669 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,901,843 | 515,721 | Shares | Sole | 2026-08-18 | |
| 2025-12-31 | $8,514,553 | 515,721 | Shares | Sole | 2026-08-18 | |
| 2025-09-30 | $7,754,710 | 534,071 | Shares | Sole | 2026-08-18 | |
| 2025-06-30 | $6,626,993 | 473,695 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $7,990,937 | 587,785 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,057,675 | 346,304 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,087,835 | 346,304 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,041,178 | 346,304 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $7,106,158 | 346,304 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $7,478,745 | 348,497 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,189,493 | 348,497 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,382,146 | 148,497 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,330,362 | 144,547 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,964,232 | 142,547 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,764,036 | 122,647 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,521,326 | 85,672 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,364,209 | 104,576 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,658,737 | 104,456 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,347,256 | 66,348 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,289,930 | 41,942 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,377,758 | 41,642 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $4,851,546 | 57,922 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,068,143 | 57,721 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,385,683 | 57,307 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,191,358 | 125,149 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||